Clinical Trial Update: Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma [NA]

View source ↗

Summary

This clinical trial update notes ongoing recruitment for postoperative adjuvant therapy with donafenib in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Donafenib (donafenib)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Hepatocellular Carcinoma, Adjuvant Therapy | NA | Status: RECRUITING